Filing Details
- Accession Number:
- 0000899243-21-035331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-08 16:15:19
- Reporting Period:
- 2021-09-07
- Accepted Time:
- 2021-09-08 16:15:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1789972 | Cullinan Oncology Inc. | CGEM | Biological Products, (No Disgnostic Substances) (2836) | 813867811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1837456 | Leigh Zawel | C/O Cullinan Oncology, Inc. One Main Street, Suite 520 Cambridge MA 02142 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-07 | 28,118 | $28.95 | 65,406 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 26, 2021.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.62 to $29.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
